Hanmi Pharmaceutical And Beijing Hanmi Progress Clinical Trials Of Co-Developed BH3120 As A Next-Generation Cancer Immunotherapy

Press/Media: Press / Media

Period2024 Nov 24 → 2024 Nov 25

Media coverage

93

Media coverage